Literature DB >> 6119360

A comparison of the effects of sympathomimetic agents on gastric acid secretion by the rat stomach in vivo and in vitro.

S P Canfield, C A Price.   

Abstract

1. The action of isoprenaline on gastric acid secretion in rats with Heidenhain pouches has been compared with its action in a rat isolated stomach preparation. 2. Isoprenaline (40 micrograms kg-1 h-1) inhibited the acid secretion in response to pentagastrin (20 micrograms kg-1 h-1) in conscious rate with Heidenhain pouches. 3. This inhibition could be abolished by propranolol (2 mg kg-1) and butoxamine (8 mg kg-1) and partially reversed by practolol (8 mg kg-1). 4. Propranolol (2 mg kg-1) significantly increased the response to pentagastrin (20 micrograms kt-1 h-1) but butoxamine and practolol (both at 8 mg kg-1) and the inactive isomer (+)-propranolol (2 mg kg-1) were without any effect on the pentagastrin response in the rats with pouches. 5. In the rat isolated stomach preparation isoprenaline stimulated acid secretion over the range 10(-7) M-10(-3) M whereas phenylephrine and methoxamine were without effect. 6. Propranolol (2 X 10(-5) M) inhibited this stimulatory effect of isoprenaline in vitro but (+)-propranolol (2 X 10(-5) M), practolol and butoxamine (both at 10(-4) M) had no effect on the response. 7. Propranolol (2 X 10(-5) M) did not have any effect on the response of the isolated stomach to pentagastrin (5 X 10(-7) M) or bethanechol (1.7 X 10(-5) M). 8. Phenylephrine (2 X 10(-5) M) did not affect the in vitro responses to pentagastrin (2.17 X 10(-7) M), bethanechol (1.7 X 10(-5) M) or histamine (5.4 X 10(-5) M). 9. It is concluded that isoprenaline has a direct stimulatory effect and an indirect inhibitory effect on gastric acid secretion in the rat. Both effects involve stimulation of beta-adrenoceptors. The relative predominance of one or other of these two opposing effects may help to explain the contradictory results in the literature regarding the actions of beta-adrenoceptor agonists on gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119360      PMCID: PMC1248132          DOI: 10.1113/jphysiol.1981.sp013768

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  16 in total

1.  Preparation of chronic denervated gastric pouches in the rat.

Authors:  R S ALPHIN; T M LIN
Journal:  Am J Physiol       Date:  1959-08

2.  Acid secretion by guinea-pig isolated stomach.

Authors:  P Holton; J Spencer
Journal:  J Physiol       Date:  1976-02       Impact factor: 5.182

3.  Effects of catecholamines on acid secretion by bullfrog isolated gastric mucosa.

Authors:  C D Thorpe; P Bass; R A Frusco; C C Hug
Journal:  Surg Forum       Date:  1971

4.  Effects of propranolol on gastric secretion in albino rats.

Authors:  P K Debnath; K D Gode; D G Das; A K Sanyal
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

5.  Can the actions of adrenoceptor agonists and antagonists on pentagastrin-induced gastric secretion be due to their effects of histamine formation?

Authors:  B P Curwain; P Holton; R L McIsaac; J Spencer
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

6.  Enhancement by propranolol of gastric acid secretion in response to pentagastrin in conscious dogs.

Authors:  B P Curwain; P Holton; J Spencer
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

Review 7.  A review: the agents and actions of sympathetic nerve and catecholamine inhibition of gastric mucosal function.

Authors:  D J Sanders
Journal:  Agents Actions       Date:  1976-07

8.  Further studies on the mode of action of isoprenaline on gastric secretion in the conscious rat.

Authors:  L Lundell; S E Svensson; G Nilsson
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Rat gastric mucosal cAMP and cGMP after adrenergic stimulation and blockade.

Authors:  H J Ruoff
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

10.  Implication of gastric mucosal histamine in inhibition by isoprenaline of pentagastrin-induced gastric secretion.

Authors:  L Lundell; S E Svensson
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

View more
  8 in total

1.  The action of beta-adrenoceptor agonists on acid secretion by the rat isolated stomach.

Authors:  S P Canfield; A D Hughes; C A Price; J E Spencer
Journal:  J Physiol       Date:  1981-07       Impact factor: 5.182

2.  Beta-adrenoceptor agonist stimulation of acid secretion by rat stomach in vitro is mediated by 'atypical' beta-adrenoceptors.

Authors:  P Canfield; P Paraskeva
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

3.  The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach.

Authors:  S P Canfield; J E Spencer
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

4.  The effect of drugs acting on cholinoceptors and mucosal chloride on luminal bicarbonate transport by rat caecum under in vitro conditions.

Authors:  P Canfield; T Abdul-Ghaffar
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

5.  Potentiating action of hexoprenaline on 14C-aminopyrine uptake by isolated rat parietal cells.

Authors:  S Maśliński; H J Ruoff
Journal:  Experientia       Date:  1984-05-15

6.  Action of histamine and of some H2-antagonists on gastric secretion 'in vitro'.

Authors:  G Coruzzi; M Adami; G Bertaccini
Journal:  Agents Actions       Date:  1984-04

Review 7.  Gastric acid secretion: activation and inhibition.

Authors:  G Sachs; C Prinz; D Loo; K Bamberg; M Besancon; J M Shin
Journal:  Yale J Biol Med       Date:  1994 May-Aug

8.  Effect of selective β-adrenoceptor blockade and surgical resection of the celiac-superior mesenteric ganglion complex on delayed liquid gastric emptying induced by dipyrone, 4-aminoantipyrine, and antipyrine in rats.

Authors:  A M Vinagre; E F Collares
Journal:  Braz J Med Biol Res       Date:  2016-02-02       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.